Observation on the effect of compound glycyrrhizin combined recombinant human epidermal growth factor in treatment of 60 patients with eczema
10.3760/cma.j.issn.1008-6706.2011.14.010
- VernacularTitle:复方甘草酸苷联合重组人表皮生长因子治疗湿疹60例疗效观察
- Author:
Yuelan GAO
;
Yanxia SONG
- Publication Type:Journal Article
- Keywords:
Compound glycyrrhizin;
Recombinant human epidermal growth factor;
Eczema
- From:
Chinese Journal of Primary Medicine and Pharmacy
2011;18(14):1892-1893
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effect and safety of the compound glycyrrhizin combined recombinant human epidermal growth factor in treatment of eczema. Methods 120 eczema patients were selected randomly divided into the treatment group (n=60) and the control group (n=60) ,the treatment group intravenously given compound glycyrrhizin once a day, 60ml combined recombinant human epidermal growth factor analgesic spray, three times a day. The control group were given intravenously compound glycyrrhizin,once a day ,60ml. Two groups of patients were continuous treatment after a month observation curative effect and adverse reaction. Results The effective rate in the treatment group(91. 67%) was higher than the control group(71.67%) ,there was significant difference(x2=6.43,P＜0.05). Compared with control group, VAS of the treatment group was significantly reduced, there is significant difference (P＜0.05). In the same group,within one month after treatment,before treatment and after treatment compared also has difference, there are significant difference (P＜0.05). The two groups had no serious adverse reactions. Conclusion Effect of compound glycyrrhizin combined recombinant human epidermal growth factor in treatment of eczema curative was distinct,which was worth extending.
